Latest Implantica News & Updates

See the latest news and media coverage for Implantica. We track all announcements, press releases, and industry mentions in real time, all in one place.

Implantica

Developer of implantable medical devices and eHealth platforms

implantica.com

Headquarters: Zug, Switzerland
Founded year: 2003
Company type: Public company
Number of employees: 50–200
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about Implantica

In short: Implantica received FDA premarket approval for its RefluxStop device and initiated plans for a commercial rollout in the United States.

Company announcements

August 25 Implantica

Implantica hosts a Capital Markets Day in Stockholm on September 9

The meeting outlines the U.S. launch strategy following FDA approval and features participating surgeons and patients.

August 20 Implantica

Implantica gains US market access via FDA approval

The company secured Premarket Approval for RefluxStop, enabling a targeted commercial launch to treat GERD in the largest medical device market globally.

August 6 Implantica

Implantica presents its eHealth platform and RefluxStop clinical results

The e-InVivo platform enables remote monitoring and treatment adjustment of smart implants. RefluxStop demonstrated excellent outcomes in a five-year CE study.

July 29 Implantica

Implantica brings RefluxStop™ to the U.S.

The post educates on GERD symptoms and highlights RefluxStop as a minimally invasive procedure, pending FDA approval.

Media coverage

September 11 Citeline

FDA Approval In Hand, Implantica Prepares To Launch Mechanical GERD Fix In US

Implantica is launching RefluxStop in the US after a PMA approval that was based entirely on European trial data. A Medicare pass-through decision is expected...

August 21 Dagens industri

Continued losses for Implantica

The medtech company Implantica, active in the implant area, reports an operating result of minus 4.2 million euros (minus 4.5) for the...

August 21 MedPage Today

GI Doc Awakes to Bat in Mouth; Stopped Farting? Uh-Oh; FDA Approves GERD Implant | MedPage Today

The FDA granted premarket approval to RefluxStop, a non-drug implant device for treating gastroesophageal reflux disease (GERD), according to maker Implantica.

August 21 Yahoo Finance

Implantica AG (OSTO:IMP A SDB) (Q2 2026) Earnings Call Highlights: FDA Approval...

Implantica AG (OSTO:IMP A SDB) reports 66% revenue growth and outlines a strategic, step-by-step U.S. market entry following RefluxStop's FDA approval.

Never miss news about Implantica

Track Implantica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Implantica competitors & trending companies

Browse news for competitors to Implantica and other trending companies.